MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Harvard Bioscience Cash Conversion Cycle 2011-2025 | HBIO
Annual Cash Conversion Cycle Harvard Bioscience
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 208 | 210 | 200 | 198 | 183 | 187 | 180 | 159 | 155 | 158 | 132 | 144 | 141 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 210 | 132 | 173 |
Quarterly Cash Conversion Cycle Harvard Bioscience
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 234 | 239 | 233 | - | 251 | 228 | 233 | - | 233 | 214 | 213 | - | - | 113 | 230 | - | 183 | 173 | 187 | - | 208 | 227 | 213 | 172 | 192 | 176 | 199 | 165 | 195 | 162 | 161 | 163 | 188 | 179 | 214 | 142 | 152 | 142 | 145 | 137 | 151 | 132 | 148 | 127 | 151 | 143 | 130 | 110 | 131 | 128 | 129 | 127 | 135 | 126 | 128 | 124 | 135 | 67.3 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 251 | 67.3 | 170 |
Cash Conversion Cycle of other stocks in the Medical instruments industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
37.9 | $ 24.56 | 0.7 % | $ 1.13 B |  USA |
 |
Baxter International
BAX
|
262 | $ 19.52 | 1.93 % | $ 9.96 B | USA |
 |
Becton, Dickinson and Company
BDX
|
110 | $ 200.48 | -0.23 % | $ 57.7 B | USA |
 |
Luminex Corporation
LMNX
|
18.9 | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
95.3 | - | -9.52 % | $ 20.6 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
266 | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
204 | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
400 | - | -1.18 % | $ 3.4 B | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
11.9 | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
194 | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
143 | $ 148.28 | -0.1 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
58.7 | $ 170.21 | 0.82 % | $ 5.31 B | USA |
 |
Alcon
ALC
|
134 | $ 79.15 | 0.43 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
185 | $ 41.07 | -3.09 % | $ 1.93 B | USA |
 |
Atrion Corporation
ATRI
|
253 K | - | - | $ 810 M | USA |
 |
electroCore
ECOR
|
2.97 | $ 4.85 | 2.11 % | $ 26.7 K | USA |
 |
Repro Med Systems
KRMD
|
149 | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
124 | $ 13.42 | 2.13 % | $ 548 M | USA |
 |
The Cooper Companies
COO
|
210 | $ 81.36 | -0.88 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
28.7 | $ 83.04 | -1.14 % | $ 1.86 B | USA |
 |
Glaukos Corporation
GKOS
|
170 | $ 111.73 | 2.6 % | $ 5.41 B | USA |
 |
Masimo Corporation
MASI
|
83.7 | $ 137.35 | -0.72 % | $ 7.32 B | USA |
 |
Haemonetics Corporation
HAE
|
217 | $ 80.24 | -3.89 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
24.9 | $ 9.22 | -0.27 % | $ 190 M | USA |
 |
Merit Medical Systems
MMSI
|
171 | $ 86.49 | -0.24 % | $ 5.04 B | USA |
 |
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
208 | $ 559.7 | 3.2 % | $ 199 B | USA |
 |
OraSure Technologies
OSUR
|
167 | $ 2.49 | - | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
-52.9 | $ 2.23 | -7.65 % | $ 22.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
545 | $ 0.36 | -7.4 % | $ 28.7 M | USA |
 |
Nephros
NEPH
|
161 | $ 4.98 | -0.8 % | $ 51.7 M | USA |
 |
NeuroMetrix
NURO
|
357 | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
167 | $ 251.67 | -0.27 % | $ 36.8 B | USA |
 |
Envista Holdings Corporation
NVST
|
79.4 | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
193 | $ 44.0 | 1.43 % | $ 145 M | USA |
 |
STAAR Surgical Company
STAA
|
26 | $ 23.49 | -2.65 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
112 | $ 253.98 | 0.82 % | $ 25 B | USA |
 |
Stereotaxis
STXS
|
212 | $ 2.35 | -1.05 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
36.5 | $ 14.04 | -1.4 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
-241 | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
272 | $ 160.09 | 1.72 % | $ 8.92 M | USA |
 |
Utah Medical Products
UTMD
|
280 | $ 57.54 | -0.96 % | $ 209 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
63.9 | $ 11.43 | -1.21 % | $ 2.32 B | USA |
 |
Retractable Technologies
RVP
|
250 | $ 0.84 | 1.99 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
183 | $ 126.88 | 0.17 % | $ 5.94 B | USA |
 |
West Pharmaceutical Services
WST
|
98.9 | $ 271.82 | 1.6 % | $ 19.8 B | USA |